Fig 3, C-G, right, further shows that such decreases of CCR7, HLA-DR, CD83, and CD86 were significant in the response group from baseline to week 26. Fig E4, in the Online Repository available at www.jaci-global.org, presents expression levels of FcεRI, CCR7, HLA-DR, and costimulatory molecules on pDCs from individual asthma patients measured at weeks 0 and 26. The gene discussed is FCER1A; the disease is asthma.